Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 70.00
+1.10 (1.60%)
At close: Jan 20, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.56 billion as of January 21, 2026. Its market cap has increased by 114.48% in one year.
Market Cap
3.56B
Enterprise Value
3.17B
Revenue
159.02M
Ranking
n/a
PE Ratio
169.81
Stock Price
70.00
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.56B, an increase of 156.00%. That is a compound annual growth rate of 87.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.53B | -1.43% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 45.64T |
| Hon Hai Precision Industry | 3.20T |
| Delta Electronics | 2.91T |
| MediaTek | 2.37T |
| ASE Technology Holding | 1.30T |
| Fubon Financial Holding | 1.30T |
| Cathay Financial Holding | 1.14T |
| Quanta Computer | 1.09T |